A detailed history of Kerrisdale Advisers, LLC transactions in Cronos Group Inc. stock. As of the latest transaction made, Kerrisdale Advisers, LLC holds 458,247 shares of CRON stock, worth $884,416. This represents 0.38% of its overall portfolio holdings.

Number of Shares
458,247
Previous 458,247 -0.0%
Holding current value
$884,416
Previous $1.07 Million 5.53%
% of portfolio
0.38%
Previous 0.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.27 - $3.02 $13,154 - $17,500
-5,795 Reduced 1.25%
458,247 $1.07 Million
Q1 2024

May 15, 2024

SELL
$1.93 - $2.7 $48,250 - $67,500
-25,000 Reduced 5.11%
464,042 $1.21 Million
Q4 2023

Feb 14, 2024

SELL
$1.72 - $2.19 $404,475 - $515,000
-235,160 Reduced 32.47%
489,042 $1.02 Million
Q3 2023

Nov 14, 2023

BUY
$1.68 - $2.47 $1.22 Million - $1.79 Million
724,202 New
724,202 $1.45 Million

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $729M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Kerrisdale Advisers, LLC Portfolio

Follow Kerrisdale Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerrisdale Advisers, LLC with notifications on news.